|
Age (years)
|
57.5 ± 8.3
|
46.7 ± 7.2
|
0.000
|
52.6 ± 7.0
|
51.5 ± 6.8
|
0.1486
|
|
Sex (female)
|
485(57.9%)
|
108(38.2%)
|
0.000
|
56(33.9%)
|
58(35.2%)
|
0.817
|
|
Body mass index
|
25.2 ± 2.2
|
24.5 ± 1.3
|
0.000
|
25.6 ± 2.0
|
25.5 ± 2.0
|
0.6500
|
|
Rheumatic valvular disease (n)
|
468(55.9%)
|
162(57.2%)
|
0.384
|
94(57.0%)
|
96(58.2%)
|
0.487
|
|
Hypertension
|
302(36.1%)
|
60(21.2%)
|
0.000
|
36(21.8%)
|
35(21.2%)
|
0.893
|
|
Diabetes mellitus
|
143(17.1%)
|
56(19.8%)
|
0.304
|
30(18.1%)
|
31(18.8%)
|
0.887
|
|
Preoperative creatinine (mg/dL)
|
0.72 ± 0.19
|
0.77 ± 0.10
|
0.000
|
0.74 ± 0.13
|
0.75 ± 0.12
|
0.4683
|
|
LVEF, %
|
56.7 ± 6.9
|
61.6 ± 4.7
|
0.000
|
59.2 ± 4.2
|
59.5 ± 4.0
|
0.5069
|
|
Current congestive heart failure
|
259(30.9%)
|
51(18.0%)
|
0.000
|
38(23.0%)
|
36(21.8%)
|
0.792
|
|
History of AF
|
378(45.2%)
|
85(30.0%)
|
0.000
|
60(36.4%)
|
58(35.2%)
|
0.818
|
|
COPD
|
134(16.0%)
|
26(9.2%)
|
0.005
|
20(12.1%)
|
18(10.9%)
|
0.730
|
|
Cerebrovascular disease
|
76(9.1%)
|
14(4.9%)
|
0.027
|
11(6.7%)
|
10(6.1%)
|
0.822
|
|
preoperative NYHA functional class
|
2.6 ± 0.6
|
2.1 ± 0.5
|
0.0000
|
2.3 ± 0.5
|
2.3 ± 0.4
|
1.0000
|
|
NYHA III-IV functional class, n (%)
|
242(28.9%)
|
43(15.2%)
|
0.000
|
34(20.6%)
|
32(19.4%)
|
0.783
|
|
Pulmomary Hypertension (≥60 mmHg)
|
252(30.1%)
|
78(27.6%)
|
0.417
|
47(28.5%)
|
46(27.9%)
|
0.903
|
|
EuroSCORE I
|
6.5 ± 1.0
|
4.8 ± 0.8
|
0.000
|
5.9 ± 0.9
|
5.8 ± 0.8
|
0.287
|
